CAR T-Cell Therapy Market Expected to Reach $35.9 Billion by 2032

Kanika05 Sep, 2025Health

The global CAR T-cell therapy market size was valued at $2.69 billion in 2022, and is projected to reach $35.9 billion by 2032, growing at a CAGR of 28.5% from 2022 to 2032. The growth of the CAR T-cell therapy market is driven by rising cancer prevalence, increasing clinical trial success rates, regulatory approvals, and advancements in gene editing technologies. Additionally, growing investments by biotechnology firms and demand for personalized medicine further contribute to the growth of the market.